This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wiley, J. A. Articles by Harmsen, A. G. Search for Related Content PubMed PubMed Citation Articles by Wiley, J. A. Articles by Harmsen, A. G.

(American Journal of Pathology. 1999;154:919-926.)
© 1999 American Society for Investigative Pathology

Regular Articles

Bone Marrow-Derived Cells Are Required for the Induction of a Pulmonary Inflammatory Response Mediated by CD40 Ligation

From the Trudeau Institute, Saranac Lake, New York

The expression of inflammatory mediators by various cells following in vitro CD40 ligation is well known. However, knowledge of the role and interaction with these cells in the establishment and maintenance of in vivo immune-mediated inflammation is limited. In this report, a chimeric mouse model based on CD40 knockout and wild-type mice was used to assess the role of bone marrow (BM)-derived and non-BM-derived cells in a CD40-mediated pulmonary inflammation response. CD40+ BM-derived cells were required for initial cell recruitment, pulmonary edema, and weight loss associated with this response. The structural CD40+ non-BM-derived cells of the lung, such as fibroblasts, epithelial cells, and endothelial cells, could not by themselves establish any level of pulmonary inflammation. However, both the CD40+ BM-derived cells and the structural CD40+ non-BM-derived cells of the lung were required to maximize the level of pulmonary inflammation. Both B cells and T cells played a contributing role in macrophage recruitment and pulmonary edema but neither contributed to the inflammation-associated weight loss. These experiments indicate that CD40+ BM-derived cells were critical to the induction of pulmonary inflammation and that alveolar macrophages, B cells, and T cells contributed to selective aspects of the response.

This article has been cited by other articles:

				J. A. Wiley and A. G. Harmsen Pneumocystis Infection Enhances Antibody-Mediated Resistance to a Subsequent Influenza Infection J. Immunol., April 15, 2008; 180(8): 5613 - 5624. [Abstract] [Full Text] [PDF]

				K. Kimura, H. Moriwaki, M. Nagaki, M. Saio, Y. Nakamoto, M. Naito, K. Kuwata, and F. V. Chisari Pathogenic Role of B Cells in Anti-CD40-Induced Necroinflammatory Liver Disease Am. J. Pathol., March 1, 2006; 168(3): 786 - 795. [Abstract] [Full Text] [PDF]

				Z. Zhao, Y. Qian, D. Wald, Y.-F. Xia, J.-G. Geng, and X. Li IFN Regulatory Factor-1 Is Required for the Up-Regulation of the CD40-NF-{kappa}B Activator 1 Axis During Airway Inflammation J. Immunol., June 1, 2003; 170(11): 5674 - 5680. [Abstract] [Full Text] [PDF]

				R. S. Kornbluth The emerging role of CD40 ligand in HIV infection J. Leukoc. Biol., September 1, 2000; 68(3): 373 - 382. [Abstract] [Full Text] [PDF]

				S. M. Propst, R. Denson, E. Rothstein, K. Estell, and L. M. Schwiebert Proinflammatory and Th2-Derived Cytokines Modulate CD40-Mediated Expression of Inflammatory Mediators in Airway Epithelia: Implications for the Role of Epithelial CD40 in Airway Inflammation J. Immunol., August 15, 2000; 165(4): 2214 - 2221. [Abstract] [Full Text] [PDF]